Scientific report 2020 of the Infectious Diseases Working Party (IDWP)

In May 2020, in the middle of SRAS-CoV-2 pandemic, the Chair and Secretary of the IDWP changed. Now, Rafael de la Camara (Madrid, Spain) is the Chair and Dina Averbuch (Jerusalem, Israel) is the new Secretary. We have to thank Dr Jan Styczynski and Dr Malgorzata Mikulska, previous Chair and Secretary, for the excellent work done in the previous four years with a characteristic friendly attitude.

SARS-CoV-2 pandemic has been an important focus for IDWP. At the early stage of the pandemic, the IDWP produced guidelines for the management of SARS-CoV-2 in SCT. The first one was released on March the 1^st, and the last update (the 12^th version) on December the 2^nd, 2020.

As SARS-CoV-2 pandemic has broader implications for SCT and cellular therapies, that goes further from the infectious aspects, a COVID-19 task force has been created to have a holistic approach to the effects of the pandemic. The IDWP is part of this new task force.

In 2021 we are going to launch an annual online certificated course on Infections in HSCT recipients (with an exam and CME credits), that we think will contribute to a better knowledge and management of these frequent complications of HSCT.

The IDWP will incorporate several Subcommittees to push forward the research and education of the different infections.

1. 23^rd IDWP Educational Course “Infectious complications following HSCT: Vision 2020” – Oct 28-30, 2020 / [Virtual].